Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alignment Healthcare (ALHC) Non-Current Debt (2020 - 2025)

Historic Non-Current Debt for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $322.7 million.

  • Alignment Healthcare's Non-Current Debt rose 5340.18% to $322.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $322.7 million, marking a year-over-year increase of 5340.18%. This contributed to the annual value of $321.4 million for FY2024, which is 9864.16% up from last year.
  • Alignment Healthcare's Non-Current Debt amounted to $322.7 million in Q3 2025, which was up 5340.18% from $322.3 million recorded in Q2 2025.
  • Alignment Healthcare's 5-year Non-Current Debt high stood at $322.7 million for Q3 2025, and its period low was $145.7 million during Q1 2021.
  • For the 5-year period, Alignment Healthcare's Non-Current Debt averaged around $196.8 million, with its median value being $161.4 million (2023).
  • Over the last 5 years, Alignment Healthcare's Non-Current Debt had its largest YoY gain of 9864.16% in 2024, and its largest YoY loss of 56.42% in 2024.
  • Quarter analysis of 5 years shows Alignment Healthcare's Non-Current Debt stood at $150.6 million in 2021, then grew by 6.83% to $160.9 million in 2022, then grew by 0.57% to $161.8 million in 2023, then soared by 98.64% to $321.4 million in 2024, then grew by 0.41% to $322.7 million in 2025.
  • Its Non-Current Debt was $322.7 million in Q3 2025, compared to $322.3 million in Q2 2025 and $321.9 million in Q1 2025.